Ruhunu Hospital invests in and partners Creedence Genomics
Ruhunu Hospital (Pvt.) Ltd, a trusted name in Healthcare in the Southern Province recently invested in Creedence Genomics, a company that is changing how diagnostics is done and has paved the way for the future by using Next Generation Sequencing (NGS).
Moreover, it is a pioneer in locally commercialising genomic tests based on (NGS) technology.
NGS is cutting edge due to its speed, accuracy and the comprehensive nature of test results. The company has developed tests to diagnose critical noncommunicable diseases (NCDS) such as cancer, heart diseases and infectious diseases, and screening tests to assess the susceptibility for the same.
Ruhunu Hospital CO-CEO Raveen Wickramasinghe said: “Since December 2015, with the launch of Ruhunu Hospital Diagnostics (RHD), the vision of the company is to be the laboratory service provider of choice by offering advanced technology, exceptional health information delivery, and superior customer services of the international standard. Today I am thrilled to state that a Sri Lankan company is taking an initiative in cutting edge technology.”
“The key determining factor for our investment has been the Apollo contract that has been secured. While we were focusing on our due diligence we were very pleased with the team and especially the CEO Dr. Vaz Gnannam the visionary scientist who made this come true. Vaz and I have become business partners as well as friends throughout the last few months and I am confident that with the support of myself and the management of Ruhunu Hospital we can attract more investments and bring along strategic partnerships to the business. We are also excited to see the product innovation and expansion of the laboratories in the South Asia region,” Wickramasinghe noted. Creedence Genomics CEO Dr. Vaz Gnannam said: “It’s a pleasure to work with forward thinking entrepreneurs in the healthcare space. Ruhunu is poised to be an innovative healthcare infrastructure and service provider with their support of dynamic and strategic collaborations.”